• 검색 결과가 없습니다.

Biologic behavior of resected BRCA-mutated pancreatic cancer: Comparison with sporadic pancreatic cancer and other BRCA-related cancers

N/A
N/A
Protected

Academic year: 2021

Share "Biologic behavior of resected BRCA-mutated pancreatic cancer: Comparison with sporadic pancreatic cancer and other BRCA-related cancers"

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

AHBPSAnnals of Hepato-Biliary-Pancreatic Surgery

www.ahbps.org S149

Biologic behavior of resected BRCA-mutated pancreatic cancer: Comparison with sporadic pancreatic cancer and other BRCA-related cancers

Sung Hyun KIM, Chang Moo KANG*

Department of Hepatobiliary and Pancreatic Surgery, Yonsei University College of Medicine, Seoul, Korea

BP-PP-1-2

Introduction: Since margin-negative resection is essential for the cure of pancreatic cancer (PC), early detection of PC is important.

Although PC is the third most common cancer associated with BRCA1/2 mutations, clinical research regarding BRCA mutations in resected PC are rare. In this study, we investigated the oncologic characteristics of resected PC with BRCA mutation to suggest man- agement strategies.

Methods: We retrospectively reviewed data from 493 patients who were confirmed to be pathogenic BRCA1/2 mutation carriers be- tween January 2007 and December 2019. We investigated the oncologic characteristics of PC patients by comparing them with resect- ed sporadic PC and other BRCA-related cancer groups (breast cancer, ovarian cancer, and others).

Results: Ten BRCA mutation carriers (2.0%) experienced PC, and PC onset was significantly later than that of BRCA-related breast cancer (age: breast vs. pancreas, 45.0 vs. 53.5 years; p = 0.050). Six patients underwent pancreatectomy and their long-term survival outcomes did not differ from those of sporadic PC patients (disease free survival: BRCA1/2 vs. sporadic, 10.0 months vs. 9.0 months; p

= 0.504; overall survival: BRCA1/2 vs. sporadic, 29.0 months vs. 35.0 months; p = 0.520).

Conclusions: BRCA-mutated PC occurs later than BRCA-mutated breast cancer. Active genetic testing to identify BRCA1/2 muta- tion carriers at the onset of breast cancer and continuous long-term surveillance of these patients can provide opportunities to detect BRCA-mutated PC at a resectable stage.

pISSN: 2508-5778ㆍeISSN: 2508-5859

Ann Hepatobiliary Pancreat Surg 2021;25 Suppl 1:S149 https://doi.org/10.14701/ahbps.BP-PP-1-2

Corresponding Author: Chang Moo KANG ([email protected]) Presenter: Sung Hyun KIM ([email protected])

Copyright Ⓒ The Korean Association of Hepato-Biliary-Pancreatic Surgery

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

참조

관련 문서

Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients?.

Specifically, the prevalence and incidence rates of cancer among chronic diseases are continuously increasing, while early diagnosis and treatment of cancer

Analysing this research material, The present study were examined that extravasated blood and cancer had interrelationship by comparing cancer patients

Results: 44 of 1048 patients with gastric cancer(4.1%) had synchronous and metachronous cancers. The average time interval between gastric cancer and secondary primary cancer

In this study, to investigate how applying a critical pathway to stomach cancer patients affects their recovery and treatment, the clinical effect of the critical

The purpose of this study was to identify the frequency and related factors of advanced airway management for patients with cardiac arrest by the

Inhibitory effects of the concentration of methanol extracts from Plantago Asiatica against the COX-2 protein expression and iNOS expression of the MDA-MB-231 human

 A novel and rapid prognostic nomogram was developed using quick Sequential Organ Failure Assessment score and mean platelet volume to identify cancer patients with